SOL/USDT 1H K-Line Analysis & Trade Plan


$SOL #SummerCreationCamp
Market Structure.

The 1-hour chart shows short-term bullish momentum. SOL has recovered from around 73.46 and is now trading near 75.05, holding above all major moving averages.

Technical Overview
Price: 75.05
24H High: 75.23
24H Low: 73.55
MA5: 75.06
MA10: 74.88
MA30: 74.40
EMA30: 74.65.

The bullish alignment of the moving averages indicates buyers remain in control.

Indicator Analysis
Trend
Price is above MA5, MA10, and MA30.
Higher highs and higher lows confirm an uptrend.
MACD
DIF remains above DEA.
Histogram is positive, indicating bullish momentum, though momentum is beginning to flatten, suggesting a possible short consolidation.
KDJ
K: 82.84
D: 83.29
J: 81.93
KDJ is in the overbought zone, so a brief pullback or sideways movement is possible before another upward leg.
Key Levels
Support
74.85
74.40
73.90
Resistance
75.23
75.90
76.50.

Trade Plan
Bullish Setup
Entry: 74.90–75.10 (or on a confirmed breakout above 75.25)
Stop Loss: 74.35
Targets
TP1: 75.60
TP2: 76.00
TP3: 76.50.

Bearish Scenario
If SOL loses 74.40 with strong volume:
Downside target: 73.90
Extended target: 73.50.

Risk Management
Risk no more than 1–2% of trading capital on a single trade.
Move the stop loss to breakeven after TP1 is reached.

Watch Bitcoin's price action, as it is likely to influence SOL's next move.

Outlook.

The 1-hour chart remains bullish with healthy trend structure. As long as SOL holds above 74.40–74.65, buyers retain the advantage. A decisive breakout above 75.23 could trigger momentum towards 75.90–76.50, while rejection at resistance may lead to a short-term pullback before the trend resumes.
Bias: Bullish with cautious optimism near resistance.
SOL1.50%
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned